NCT01047202已完成4 期
A Blinded, Randomized and Controlled Clinical Trial With Influenza A/H1N1 Split-virion Vaccine in 6 to 35 Months Infants
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 310
- 试验地点
- 1
- 主要终点
- Evaluate immunogenicity of H1N1 vaccine with seasonal influenza vaccine in infants
研究概览
简要总结
A single center, observer-masked, randomized clinical trial is to be conducted in 6-35 months infants to evaluate the safety and immunogenicity of Sinovac's influenza A/H1N1 Vaccine (PANFLU.1).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Care Provider)
入排标准
- 年龄范围
- 6 Months 至 35 Months（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy male or female aged between 6 and 35 months
- •Full-term birth, birth weight 2,500 grams or more
- •provided birth certification or vaccination card Parent(s) or legal guardian(s) are able to understand and sign the informed consent
排除标准
- •Cases, cured cases and close contact of influenza A (H1N1) virus
- •Subject that has a medical history of any of the following: allergic history, or allergic to any ingredient of vaccine, such as egg, egg protein, etc
- •Serious adverse reactions to vaccines such as anaphylaxis, hives, respiratory difficulty, angioedema, or abdominal pain
- •Symptoms of acute infection within a week
- •Autoimmune disease or immunodeficiency
- •Congenital malformation, developmental disorders or serious chronic diseases (such as Down's syndrome, diabetes, sickle cell anemia or neurological disorders)
- •Asthma that is unstable or required emergent care, hospitalization or intubation during the past two years or that required the use of oral or intravenous corticosteroids
- •Bleeding disorder diagnosed by a doctor (e.g. factor deficiency, coagulopathy, or platelet disorder requiring special precautions) or significant bruising or bleeding difficulties with IM injections or blood draws
- •History or family history of convulsions, epilepsy, brain disease and psychiatric
- •Asplenia, functional asplenia or any condition resulting in the absence or removal o the spleen
- •Guillain-Barre Syndrome
- •Administration of 2009-2010 seasonal vaccine
- •History of any blood products within 3 months
- •Administration of any other investigational research agents within 30 days
- •Administration of any live attenuated vaccine within 30 days
- •Administration of subunit or inactivated vaccines within 14 days
- •Be receiving anti-TB prophylaxis or therapy currently
- •Axillary temperature > 37.0 centigrade at the time of dosing
- •Any medical, psychiatric, social condition, occupational reason or other responsibility that, in the judgment of the investigator, is a contraindication to protocol participation or impairs a volunteer's ability to give informed consent
结局指标
主要结局
Evaluate immunogenicity of H1N1 vaccine with seasonal influenza vaccine in infants
时间窗: 3 months
次要结局
- Evaluate safety of H1N1 vaccine with seasonal influenza vaccine in infants(3 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis InfectionTuberculosisNCT02581579Manresana de Micobacteriologia, SL24
尚未招募
不适用
A Clinical Study to Evaluate the Efficacy and Satisfaction of the Skinceuticals Skin Care Product (CE FERULIC) for Skin Repair Post Fraxel Laser TreatmentPhoto-damagingNCT06026085DeYi Aesthetic Medical Clinic50
尚未招募
不适用
A Clinical Study to Evaluate the Efficacy and Satisfaction of the Skinceuticals Skin Care Product (CE) for Skin Repair Post Fraxel Laser TreatmentPhoto-damagingNCT05813483DeYi Aesthetic Medical Clinic50
撤回
2 期
Xylitol for Otitis MediaOtitis Media With EffusionNCT02950311Duke University
尚未招募
不适用
A Clinical Study to Evaluate the Efficacy and Safety of Monopolar Radiofrequency Combined With SkinCeuticals A.G.E and Skinceuticals CE FERULIC for Improving Facial Skin Elasticity, Tightening and Fading Fine LinesSkin AgingNCT06228833Yes Skin Medical Group50